Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo

H. Gil-Henn, A. Patsialou, Yarong Wang, M. S. Warren, John S. Condeelis, A. J. Koleske

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Tumor progression is a complex, multistep process involving accumulation of genetic aberrations and alterations in gene expression patterns leading to uncontrolled cell division, invasion into surrounding tissue and finally dissemination and metastasis. We have previously shown that the Arg/Abl2 non-receptor tyrosine kinase acts downstream of the EGF receptor and Src tyrosine kinases to promote invadopodium function in breast cancer cells, thereby promoting their invasiveness. However, whether and how Arg contributes to tumor development and dissemination in vivo has never been investigated. Using a mouse xenograft model, we show that knocking down Arg in breast cancer cells leads to increased tumor cell proliferation and significantly enlarged tumor size. Despite having larger tumors, the Arg-knockdown (Arg KD) tumor-bearing mice exhibit significant reductions in tumor cell invasion, intravasation into blood vessels and spontaneous metastasis to lungs. Interestingly, we found that proliferation-associated genes in the Ras-MAPK (mitogen-activated protein kinase) pathway are upregulated in Arg KD breast cancer cells, as is Ras-MAPK signaling, while invasion-associated genes are significantly downregulated. These data suggest that Arg promotes tumor cell invasion and dissemination, while simultaneously inhibiting tumor growth. We propose that Arg acts as a switch in metastatic cancer cells that governs the decision to 'grow or go' (divide or invade).

Original languageEnglish (US)
Pages (from-to)2622-2630
Number of pages9
JournalOncogene
Volume32
Issue number21
DOIs
StatePublished - May 23 2013

Fingerprint

Breast Neoplasms
Neoplasms
Neoplasm Metastasis
ras Genes
src-Family Kinases
Mitogen-Activated Protein Kinases
Epidermal Growth Factor Receptor
Heterografts
Cell Division
Protein-Tyrosine Kinases
Blood Vessels
Down-Regulation
Cell Proliferation
Gene Expression
Lung
Growth
Genes

Keywords

  • Arg kinase
  • Breast cancer
  • invasion
  • metastasis
  • proliferation

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo. / Gil-Henn, H.; Patsialou, A.; Wang, Yarong; Warren, M. S.; Condeelis, John S.; Koleske, A. J.

In: Oncogene, Vol. 32, No. 21, 23.05.2013, p. 2622-2630.

Research output: Contribution to journalArticle

Gil-Henn, H. ; Patsialou, A. ; Wang, Yarong ; Warren, M. S. ; Condeelis, John S. ; Koleske, A. J. / Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo. In: Oncogene. 2013 ; Vol. 32, No. 21. pp. 2622-2630.
@article{68de262df64b4ba2a2588cd36ade984d,
title = "Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo",
abstract = "Tumor progression is a complex, multistep process involving accumulation of genetic aberrations and alterations in gene expression patterns leading to uncontrolled cell division, invasion into surrounding tissue and finally dissemination and metastasis. We have previously shown that the Arg/Abl2 non-receptor tyrosine kinase acts downstream of the EGF receptor and Src tyrosine kinases to promote invadopodium function in breast cancer cells, thereby promoting their invasiveness. However, whether and how Arg contributes to tumor development and dissemination in vivo has never been investigated. Using a mouse xenograft model, we show that knocking down Arg in breast cancer cells leads to increased tumor cell proliferation and significantly enlarged tumor size. Despite having larger tumors, the Arg-knockdown (Arg KD) tumor-bearing mice exhibit significant reductions in tumor cell invasion, intravasation into blood vessels and spontaneous metastasis to lungs. Interestingly, we found that proliferation-associated genes in the Ras-MAPK (mitogen-activated protein kinase) pathway are upregulated in Arg KD breast cancer cells, as is Ras-MAPK signaling, while invasion-associated genes are significantly downregulated. These data suggest that Arg promotes tumor cell invasion and dissemination, while simultaneously inhibiting tumor growth. We propose that Arg acts as a switch in metastatic cancer cells that governs the decision to 'grow or go' (divide or invade).",
keywords = "Arg kinase, Breast cancer, invasion, metastasis, proliferation",
author = "H. Gil-Henn and A. Patsialou and Yarong Wang and Warren, {M. S.} and Condeelis, {John S.} and Koleske, {A. J.}",
year = "2013",
month = "5",
day = "23",
doi = "10.1038/onc.2012.284",
language = "English (US)",
volume = "32",
pages = "2622--2630",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "21",

}

TY - JOUR

T1 - Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo

AU - Gil-Henn, H.

AU - Patsialou, A.

AU - Wang, Yarong

AU - Warren, M. S.

AU - Condeelis, John S.

AU - Koleske, A. J.

PY - 2013/5/23

Y1 - 2013/5/23

N2 - Tumor progression is a complex, multistep process involving accumulation of genetic aberrations and alterations in gene expression patterns leading to uncontrolled cell division, invasion into surrounding tissue and finally dissemination and metastasis. We have previously shown that the Arg/Abl2 non-receptor tyrosine kinase acts downstream of the EGF receptor and Src tyrosine kinases to promote invadopodium function in breast cancer cells, thereby promoting their invasiveness. However, whether and how Arg contributes to tumor development and dissemination in vivo has never been investigated. Using a mouse xenograft model, we show that knocking down Arg in breast cancer cells leads to increased tumor cell proliferation and significantly enlarged tumor size. Despite having larger tumors, the Arg-knockdown (Arg KD) tumor-bearing mice exhibit significant reductions in tumor cell invasion, intravasation into blood vessels and spontaneous metastasis to lungs. Interestingly, we found that proliferation-associated genes in the Ras-MAPK (mitogen-activated protein kinase) pathway are upregulated in Arg KD breast cancer cells, as is Ras-MAPK signaling, while invasion-associated genes are significantly downregulated. These data suggest that Arg promotes tumor cell invasion and dissemination, while simultaneously inhibiting tumor growth. We propose that Arg acts as a switch in metastatic cancer cells that governs the decision to 'grow or go' (divide or invade).

AB - Tumor progression is a complex, multistep process involving accumulation of genetic aberrations and alterations in gene expression patterns leading to uncontrolled cell division, invasion into surrounding tissue and finally dissemination and metastasis. We have previously shown that the Arg/Abl2 non-receptor tyrosine kinase acts downstream of the EGF receptor and Src tyrosine kinases to promote invadopodium function in breast cancer cells, thereby promoting their invasiveness. However, whether and how Arg contributes to tumor development and dissemination in vivo has never been investigated. Using a mouse xenograft model, we show that knocking down Arg in breast cancer cells leads to increased tumor cell proliferation and significantly enlarged tumor size. Despite having larger tumors, the Arg-knockdown (Arg KD) tumor-bearing mice exhibit significant reductions in tumor cell invasion, intravasation into blood vessels and spontaneous metastasis to lungs. Interestingly, we found that proliferation-associated genes in the Ras-MAPK (mitogen-activated protein kinase) pathway are upregulated in Arg KD breast cancer cells, as is Ras-MAPK signaling, while invasion-associated genes are significantly downregulated. These data suggest that Arg promotes tumor cell invasion and dissemination, while simultaneously inhibiting tumor growth. We propose that Arg acts as a switch in metastatic cancer cells that governs the decision to 'grow or go' (divide or invade).

KW - Arg kinase

KW - Breast cancer

KW - invasion

KW - metastasis

KW - proliferation

UR - http://www.scopus.com/inward/record.url?scp=84878256918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878256918&partnerID=8YFLogxK

U2 - 10.1038/onc.2012.284

DO - 10.1038/onc.2012.284

M3 - Article

VL - 32

SP - 2622

EP - 2630

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 21

ER -